Actelion Ltd.
Sanofi S.A.
Ranbaxy Laboratories Limited
Daiichi Sankyo Company Limited
United Therapeutics Corp
Pfizer, Inc.
Astra Zeneca Plc
Johnson & Johnson Ltd.
Takeda Pharmaceutical Company Limited
Lupin Limited
Merck & Co., Inc.
Novartis AG
Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Antihypertensive Drugs Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Antihypertensive Drugs Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Antihypertensive Drugs Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Antihypertensive Drugs Market-Segmentation by Type
5.1 ARB
5.2 CCB
5.3 Other
6 Global Antihypertensive Drugs Market-Segmentation by Application
6.1 Hypertension
6.2 PAH
6.3 Other
7 Global Antihypertensive Drugs Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence - Company Profiles
8.1 Actelion Ltd.
8.1.1 Actelion Ltd. Profile
8.1.2 Actelion Ltd. Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Actelion Ltd. Product/Solution Launches and Enhancements Analysis
8.1.4 Actelion Ltd. Business Overview/Recent Development/Acquisitions
8.2 Sanofi S.A.
8.2.1 Sanofi S.A. Profile
8.2.2 Sanofi S.A. Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Sanofi S.A. Product/Solution Launches and Enhancements Analysis
8.2.4 Sanofi S.A. Business Overview/Recent Development/Acquisitions
8.3 Ranbaxy Laboratories Limited
8.3.1 Ranbaxy Laboratories Limited Profile
8.3.2 Ranbaxy Laboratories Limited Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Ranbaxy Laboratories Limited Product/Solution Launches and Enhancements Analysis
8.3.4 Ranbaxy Laboratories Limited Business Overview/Recent Development/Acquisitions
8.4 Daiichi Sankyo Company Limited
8.4.1 Daiichi Sankyo Company Limited Profile
8.4.2 Daiichi Sankyo Company Limited Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Daiichi Sankyo Company Limited Product/Solution Launches and Enhancements Analysis
8.4.4 Daiichi Sankyo Company Limited Business Overview/Recent Development/Acquisitions
8.5 United Therapeutics Corp
8.5.1 United Therapeutics Corp Profile
8.5.2 United Therapeutics Corp Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 United Therapeutics Corp Product/Solution Launches and Enhancements Analysis
8.5.4 United Therapeutics Corp Business Overview/Recent Development/Acquisitions
8.6 Pfizer, Inc.
8.6.1 Pfizer, Inc. Profile
8.6.2 Pfizer, Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Pfizer, Inc. Product/Solution Launches and Enhancements Analysis
8.6.4 Pfizer, Inc. Business Overview/Recent Development/Acquisitions
8.7 Astra Zeneca Plc
8.7.1 Astra Zeneca Plc Profile
8.7.2 Astra Zeneca Plc Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Astra Zeneca Plc Product/Solution Launches and Enhancements Analysis
8.7.4 Astra Zeneca Plc Business Overview/Recent Development/Acquisitions
8.8 Johnson & Johnson Ltd.
8.8.1 Johnson & Johnson Ltd. Profile
8.8.2 Johnson & Johnson Ltd. Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Johnson & Johnson Ltd. Product/Solution Launches and Enhancements Analysis
8.8.4 Johnson & Johnson Ltd. Business Overview/Recent Development/Acquisitions
8.9 Takeda Pharmaceutical Company Limited
8.9.1 Takeda Pharmaceutical Company Limited Profile
8.9.2 Takeda Pharmaceutical Company Limited Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Takeda Pharmaceutical Company Limited Product/Solution Launches and Enhancements Analysis
8.9.4 Takeda Pharmaceutical Company Limited Business Overview/Recent Development/Acquisitions
8.10 Lupin Limited
8.10.1 Lupin Limited Profile
8.10.2 Lupin Limited Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Lupin Limited Product/Solution Launches and Enhancements Analysis
8.10.4 Lupin Limited Business Overview/Recent Development/Acquisitions
8.11 Merck & Co., Inc.
8.11.1 Merck & Co., Inc. Profile
8.11.2 Merck & Co., Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Merck & Co., Inc. Product/Solution Launches and Enhancements Analysis
8.11.4 Merck & Co., Inc. Business Overview/Recent Development/Acquisitions
8.12 Novartis AG
8.12.1 Novartis AG Profile
8.12.2 Novartis AG Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Novartis AG Product/Solution Launches and Enhancements Analysis
8.12.4 Novartis AG Business Overview/Recent Development/Acquisitions
9 Global Antihypertensive Drugs Market-Segmentation by Geography
10 North America
10.1 North America Antihypertensive Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Antihypertensive Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Antihypertensive Drugs Production Analysis from 2015-2020
10.4 North America Antihypertensive Drugs Consumption Analysis from 2015-2020
10.5 North America Antihypertensive Drugs Import and Export from 2015-2020
10.6 North America Antihypertensive Drugs Value, Production and Market Share by Type (2015-2020)
10.7 North America Antihypertensive Drugs Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Antihypertensive Drugs by Country (United States, Canada)
10.8.1 North America Antihypertensive Drugs Sales by Country (2015-2020)
10.8.2 North America Antihypertensive Drugs Consumption Value by Country (2015-2020)
10.9 North America Antihypertensive Drugs Market PEST Analysis
11 Europe
11.1 Europe Antihypertensive Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Antihypertensive Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Antihypertensive Drugs Production Analysis from 2015-2020
11.4 Europe Antihypertensive Drugs Consumption Analysis from 2015-2020
11.5 Europe Antihypertensive Drugs Import and Export from 2015-2020
11.6 Europe Antihypertensive Drugs Value, Production and Market Share by Type (2015-2020)
11.7 Europe Antihypertensive Drugs Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Antihypertensive Drugs by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Antihypertensive Drugs Sales by Country (2015-2020)
11.8.2 Europe Antihypertensive Drugs Consumption Value by Country (2015-2020)
11.9 Europe Antihypertensive Drugs Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Antihypertensive Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Antihypertensive Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Antihypertensive Drugs Production Analysis from 2015-2020
12.4 Asia-Pacific Antihypertensive Drugs Consumption Analysis from 2015-2020
12.5 Asia-Pacific Antihypertensive Drugs Import and Export from 2015-2020
12.6 Asia-Pacific Antihypertensive Drugs Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Antihypertensive Drugs Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Antihypertensive Drugs by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Antihypertensive Drugs Sales by Country (2015-2020)
12.8.2 Asia-Pacific Antihypertensive Drugs Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Antihypertensive Drugs Market PEST Analysis
13 Latin America
13.1 Latin America Antihypertensive Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Antihypertensive Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Antihypertensive Drugs Production Analysis from 2015-2020
13.4 Latin America Antihypertensive Drugs Consumption Analysis from 2015-2020
13.5 Latin America Antihypertensive Drugs Import and Export from 2015-2020
13.6 Latin America Antihypertensive Drugs Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Antihypertensive Drugs Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Antihypertensive Drugs by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Antihypertensive Drugs Sales by Country (2015-2020)
13.8.2 Latin America Antihypertensive Drugs Consumption Value by Country (2015-2020)
13.9 Latin America Antihypertensive Drugs Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Antihypertensive Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Antihypertensive Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Antihypertensive Drugs Production Analysis from 2015-2020
14.4 Middle East & Africa Antihypertensive Drugs Consumption Analysis from 2015-2020
14.5 Middle East & Africa Antihypertensive Drugs Import and Export from 2015-2020
14.6 Middle East & Africa Antihypertensive Drugs Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Antihypertensive Drugs Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Antihypertensive Drugs by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Antihypertensive Drugs Sales by Country (2015-2020)
14.8.2 Middle East & Africa Antihypertensive Drugs Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Antihypertensive Drugs Market PEST Analysis
15 Future Forecast of the Global Antihypertensive Drugs Market from 2020-2028
15.1 Future Forecast of the Global Antihypertensive Drugs Market from 2020-2028 Segment by Region
15.2 Global Antihypertensive Drugs Production and Growth Rate Forecast by Type (2020-2028)
15.3 Global Antihypertensive Drugs Consumption and Growth Rate Forecast by Application (2020-2028)
16 Appendix
16.1 Methodology
16.2 Research Data Source
